|
Status |
Public on Dec 08, 2021 |
Title |
Target BUB1 kinase as a therapeutic strategy for inhibiting STAT3 signal pathway in Bladder cancer |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
The incidence for bladder urothelial carcinoma (UC), a common malignancy of the urinary tract, is about three times higher in men than in women. High expression of the mitotic kinase BUB1 is associated with a subset of human cancers, but how BUB1 drive Bladder tumorigenesis mechanism was unknown. Using a microarray approach, we identified BUB1 higher expression in BC. Moreover we found BUB1, a member of the kinase family as a STAT3 interactor and phosphorylated STAT3 at Ser727 in cell of bladder cancer. In vitro binding and kinase assays showed that BUB1 directly band STAT3 and phosphorylated STAT3. Furthermore, the BUB1/STAT3 complex promoted STAT3 target gene transcription. Depletion of BUB1 and expression of BUB1 kinase mutants abrogated target gene transcription, highlighting the essential function of the kinase activity in STAT3 target gene activation. Pharmacological inhibitors of BUB1 (2OH-BNPP1) was able to inhibit the growth of Bladder cancer cell xenograft. This kinase may present an attractive candidate for drug targeting in Bladder cancer.
|
|
|
Overall design |
ShRNA was utilized to stably knock down BUB1 expression in 5637 cell line, while BUB1 WTRNA was transfected into 5637 cell line to establish stably overexpression cell model in 5637 cell line, then investigate the function of BUB1 gene in 5637 bladder cancer cell line.
|
|
|
Contributor(s) |
Ning J |
Citation(s) |
34852826 |
Submission date |
Apr 22, 2019 |
Last update date |
Dec 09, 2021 |
Contact name |
Miaomiao Wang |
E-mail(s) |
wangmim123@163.com
|
Organization name |
Second Hospital Affiliated to Tianjin Medical University
|
Department |
Urology Institute of Tianjin
|
Street address |
No. 23 Pingjiang Road, Hexi District, Tianjin
|
City |
Tianjin |
ZIP/Postal code |
300211 |
Country |
China |
|
|
Platforms (1) |
|
Samples (6)
|
|
Relations |
BioProject |
PRJNA534083 |
SRA |
SRP193336 |